홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

Dichloromethane → Paclitaxel

HRID 369475
인쇄

반응식

HRID 369475 반응식
CC(C)=O.O.[CH3:6][C:7]1[C@@H:24]([O:25][C:26]([C@H:28]([OH:45])[C@@H:29]([NH:36][C:37]([C:39]2[CH:40]=[CH:41][CH:42]=[CH:43][CH:44]=2)=[O:38])[C:30]2[CH:31]=[CH:32][CH:33]=[CH:34][CH:35]=2)=[O:27])[CH2:23][C@:19]2([OH:46])[C:20]([CH3:22])([CH3:21])[C:8]=1[C@@H:9]([O:64][C:65]([CH3:67])=[O:66])[C:10]([C@@:12]1([CH3:63])[C@H:17]([C@@H:18]2[O:47][C:48]([C:50]2[CH:51]=[CH:52][CH:53]=[CH:54][CH:55]=2)=[O:49])[C@:16]2([O:58][C:59]([CH3:61])=[O:60])[CH2:56][O:57][C@@H:15]2[CH2:14][C@@H:13]1[OH:62])=[O:11].C(Cl)Cl>>[CH3:6][C:7]1[C@@H:24]([O:25][C:26]([C@H:28]([OH:45])[C@@H:29]([NH:36][C:37]([C:39]2[CH:44]=[CH:43][CH:42]=[CH:41][CH:40]=2)=[O:38])[C:30]2[CH:31]=[CH:32][CH:33]=[CH:34][CH:35]=2)=[O:27])[CH2:23][C@:19]2([OH:46])[C:20]([CH3:21])([CH3:22])[C:8]=1[C@@H:9]([O:64][C:65]([CH3:67])=[O:66])[C:10]([C@@:12]1([CH3:63])[C@H:17]([C@@H:18]2[O:47][C:48]([C:50]2[CH:55]=[CH:54][CH:53]=[CH:52][CH:51]=2)=[O:49])[C@:16]2([O:58][C:59]([CH3:61])=[O:60])[CH2:56][O:57][C@@H:15]2[CH2:14][C@@H:13]1[OH:62])=[O:11].[CH3:43]/[CH:44]=[C:39](/[C:37]([NH:36][C@H:29]([C@@H:28]([OH:45])[C:26]([O:25][C@@H:24]1[C:7]([CH3:6])=[C:8]2[C:20]([CH3:21])([CH3:22])[C@:19]([OH:46])([C@@H:18]([O:47][C:48]([C:50]3[CH:51]=[CH:52][CH:53]=[CH:54][CH:55]=3)=[O:49])[C@@H:17]3[C@:16]4([O:58][C:59]([CH3:61])=[O:60])[CH2:56][O:57][C@@H:15]4[CH2:14][C@H:13]([OH:62])[C@@:12]3([CH3:63])[C:10]([C@@H:9]2[O:64][C:65]([CH3:67])=[O:66])=[O:11])[CH2:23]1)=[O:27])[C:30]1[CH:31]=[CH:32][CH:33]=[CH:34][CH:35]=1)=[O:38])\[CH3:40]
참가 물질실험 절차후처리출처 및 근거반응 노트

참가 물질

5

반응물 3

HCID 6344DichloromethaneHCID 36314Paclitaxel2회HCID 18366337Propan-2-one--water (1/1)2회

생성물 2

HCID 36314Paclitaxel수율 65%HCID 6436208Cephalomannine수율 1%

실험 절차

In a further embodiment of this invention, the material obtained from the acetone/water precipitation comprising at least 40% paclitaxel is further purified by conventional silica chromatography using a methylene chloride/ethylacetate elution solvent system similar to a system described in U.S. Pat. Nos. 5,618,538 and 5,480,639 to ElSohly et al. The distinctive features of the second silica chromatography step of the present invention pertain to the feed material and to the scale of operation. The feed material for the second silica chromatography column of the present invention is a large scale preparation comprising at least 40% paclitaxel obtained from the acetone/water precipitation step and typically containing 1.5-2.0 kg of solids. This material is dissolved in 5-7 L of methylene chloride and applied to a 12-in×10-ft silica gel column packed in a stainless steel pipe. Preferably a layer of Celite is added to the top of the column to prefilter the feed material. The column is eluted with a mobile phase comprising a gradient of methylene chloride to 50% methylene chloride/ethyl acetate, and fractions are collected. Fractions are pooled to obtain a heart cut with at least 65% paclitaxel and less than 1% cephalomannine with typical yields of 92%-95% of the paclitaxel present in the feed material.

후처리

  1. customis further purified by conventional silica chromatography
  2. washa methylene chloride/ethylacetate elution solvent system similar to a system
  3. customa large scale preparation
  4. additionPreferably a layer of Celite is added to the top of the column
  5. washThe column is eluted with a mobile phase
  6. customare collected

출처 및 근거

ORD 기록
ord-1bc87ab75d814ce588b9c1a00ba1ef1d
출처 데이터셋
uspto-grants-2000_10
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US06136989

반응 노트

이 페이지에서참가 물질실험 절차후처리출처 및 근거반응 노트